OrbiMed Advisors HELP Position
Active5-Fund ConvergenceOrbiMed Advisors initiated a new position in CYBIN INC. (HELP) in Q4 2025, holding $31.4M worth of shares across 3,840,500 shares.
HELP is a convergence signal: 5 specialist biotech funds hold this stock, suggesting high institutional conviction.
There is an upcoming Phase 3 readout for CYB003 in 137 days (Aug 31, 2026), making the timing of OrbiMed's position particularly relevant.
About CYBIN INC.
Clinical-stage biopharmaceutical company developing psychedelic-based therapeutics including CYB003 (deuterated psilocybin analog) for major depressive disorder and CYB004 (deuterated DMT) for generalized anxiety disorder
Full company profile →Frequently Asked Questions
Does OrbiMed Advisors own HELP?
Yes. As of Q4 2025, OrbiMed Advisors holds 3,840,500 shares of CYBIN INC. (HELP) valued at $31.4M. This data comes from their SEC 13F filing.
How many hedge funds own HELP?
5 specialist biotech hedge funds currently hold HELP, including Deep Track Capital, Tang Capital Management, RA Capital Management and 1 more. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did OrbiMed Advisors first buy HELP?
OrbiMed Advisors's position in HELP was first reported in Q4 2025. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is OrbiMed Advisors's HELP position increasing or decreasing?
OrbiMed Advisors initiated a new position in HELP in the most recent quarter. This is their first reported holding.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
HELPCompany Page →
All fund holders, insider trades, catalysts, and cash runway
OrbiMed AdvisorsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →